Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    14627790 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting FdCyd and THU for Advanced Solid Tumors
Condition: Neoplasms
Intervention: Drug: FdCyd + THU
2 Terminated SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Azacitidine;   Drug: Beta Erythropoietin
3 Recruiting A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
Conditions: Head and Neck Neoplasms;   Lung Neoplasms;   Urinary Bladder Neoplasms;   Breast Neoplasms
Interventions: Drug: 5-Fluoro-2-Deoxycytidine (FdCyd);   Drug: Tetrahydrouridine (THU)

Indicates status has not been verified in more than two years